Drugs / irradiated RBC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03426553 Comparator | Jan → Sep 2018 | cancer-related condition, hematologic disorder | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | irradiated RBC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03426553 ↗ |
| Route | Other | “received transfusion with irradiated RBC suspension” NCT03426553 ↗ |